Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 47 Melanoma 23 Neoplasm Metastasis 19 Neoplasms 18 Squamous Cell Carcinoma of Head and Neck 17 Lung Neoplasms 13 Skin Neoplasms 12 Recurrence 10 Head and Neck Neoplasms 10 Carcinoma, Renal Cell 9 Prostatic Neoplasms 8 Ovarian Neoplasms 8 Colorectal Neoplasms 8 Carcinoma, Squamous Cell 8 Breast Neoplasms 8 Urinary Bladder Neoplasms 7 Carcinoma, Merkel Cell 7 Triple Negative Breast Neoplasms 6 Colonic Neoplasms 6 Carcinoma, Basal Cell 6 Carcinoma 6 Adenocarcinoma 6 Uterine Cervical Neoplasms 5 Sarcoma 5 Pancreatic Neoplasms 5 Glioblastoma 5 Stomach Neoplasms 4 Multiple Myeloma 4 Mouth Neoplasms 4 Fallopian Tube Neoplasms 4

Interventions

Paclitaxel 3 Doxorubicin 3 Cyclophosphamide 3 Trastuzumab 2 Surgical Procedures, Operative 2 Carboplatin 2 pertuzumab 1 liposomal doxorubicin 1 cemiplimab 1 atezolizumab 1 Radiotherapy 1 Magnetic Resonance Spectroscopy 1 Lapatinib 1 Indocyanine Green 1 Anastrozole 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Invasive Breast Cancer × cemiplimab × Clear all

NCT04243616 2025-09-05

CemiHALT

Medical College of Wisconsin

Phase 2 Active not recruiting

Invasive Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡